Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Current Drug Targets|August 26, 2015
Innate and Adaptive Immune Responses in Chronic HCV InfectionLynn B DustinAntibodies (Basel, Switzerland)|April 23, 2024
Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral InfectionKahlio Mader, Lynn B DustinThe Journal of Clinical Investigation|December 25, 2010
Chemokine antagonism in chronic hepatitis C virus infectionEdgar D Charles, Lynn B DustinAntiviral Therapy|January 17, 2013
Primary, post-primary and non-specific immunoglobulin M responses in HCV infectionLynn B Dustin, Edgar D CharlesThe Journal of Clinical Investigation|January 24, 2022
Searching for escape-resistant anti-SARS-CoV-2 neutralizing antibodiesRanjeet Singh Mahla, Lynn B DustinAnnual Review of Immunology|October 28, 2006
Flying under the radar: the immunobiology of hepatitis CLynn B Dustin, Charles M RiceKidney International|July 17, 2009
Hepatitis C virus-induced cryoglobulinemiaEdgar D Charles, Lynn B DustinFrontiers in Immunology|November 18, 2014
Interferon lambda: opportunities, risks, and uncertainties in the fight against HCVStephen M Laidlaw, Lynn B DustinThe Journal of Clinical Investigation|September 15, 2022
Lessons from a large-scale COVID-19 vaccine trialRanjeet Singh Mahla, Lynn B DustinFrontiers in Immunology|November 27, 2014
The Humoral Immune Response to HCV: Understanding is Key to Vaccine DevelopmentSiobhán B Cashman, Brian D Marsden, Lynn B DustinPageof 4